IMVT

Immunovant, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$24.50

Market Cap

$4.99B

Beta

0.67

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-2.67%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-8.48%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for IMVT.